共 50 条
- [41] Design, Synthesis, and Biological Evaluation of Darunavir Analogs as HIV-1 Protease Inhibitors ACS BIO & MED CHEM AU, 2024, 4 (05): : 242 - 256
- [46] Comparative Cost-Efficacy Analysis of Darunavir/ritonavir and Other Ritonavir-Boosted Protease Inhibitors for First-Line Treatment of HIV-1 Infection in the United States HIV CLINICAL TRIALS, 2010, 11 (03): : 133 - 144
- [47] VIROLOGICAL PARAMETERS AS SURROGATE MARKERS FOR CLINICAL OUTCOME IN HIV-1 DISEASE - VERIFICATION, VARIATION, AND VALIDATION JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 10 : S19 - S24